B cell levels in synovium predict efficacy of rituximab in RA better than those in peripheral blood.

被引：0
|
作者：
Dass, S.
Coulthard, L.
Rawstron, A. C.
English, A.
Vital, E. M.
Reece, R.
Bingham, S. J.
McDermott, M.
Emery, P.
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] HMDS, Leeds, W Yorkshire, England
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S778 / S779
页数：2
相关论文
共 50 条
  • [1] Response to rituximab therapy in RA correlates with variable B cell expression in peripheral blood and synovium
    Dass, S.
    Coulthard, L.
    Rawstron, A. C.
    English, A.
    Vital, E. M.
    Reece, R.
    Bingham, S. J.
    McDermott, M.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 186 - 186
  • [2] Predicting response to rituximab in RA: Different effects of B cell depletion in blood and synovium
    Dass, S.
    Burgoyne, C. H.
    Rawstron, A. C.
    Vital, E. M.
    Reece, R. J.
    Ponchel, F.
    Emery, P.
    [J]. RHEUMATOLOGY, 2007, 46 : I17 - I17
  • [3] B-Cell depletion with rituximab in patients with RA causes a sustained suppression of CD27+ B-cells and is followed by a period of increased levels of naive B-cells in the peripheral blood.
    Roll, P
    Feuchtenberger, M
    Kneitz, C
    Tony, HP
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S567 - S567
  • [4] Relationship between clinical response, rituximab (RTX) pharmacokinetics, and peripheral B cell levels in rheumatoid arthritis (RA).
    Breedveld, F.
    Agarwal, S.
    Yin, M.
    Ng, C.
    Li, N.
    Shaw, T.
    Davies, B.
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S64 - S65
  • [5] Specific peripheral blood B-lineage cells predict response to rituximab therapy in RA: A study with high sensitivity flow cytometry
    Dass, S.
    Rawstron, A. C.
    Vital, E. M.
    Jain, S.
    Bingham, S. J.
    McGonagle, D.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 185 - 185
  • [6] Peripheral Blood Memory B Cell Numbers Predict Clinical Response Following Rituximab Treatment Of Adult and Childhood Myositis
    Aggarwal, Rohit
    Oddis, Chester V.
    Wilkerson, Erich R.
    Koontz, Diane
    Metes, Ilinca D.
    Reed, Ann M.
    Ascherman, Dana P.
    Levesque, Marc C.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S755 - S756
  • [7] MEASURES OF PERIPHERAL BLOOD B-CELL DEPLETION PREDICT RENAL RESPONSE IN PATIENTS WITH LUPUS NEPHRITIS TREATED WITH RITUXIMAB
    Mendez, L. M. Gomez
    Cascino, M. D.
    Garg, J.
    Brunetta, P.
    Dall'Era, M.
    Dragone, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 865 - 865
  • [8] Reduction in synovial B cell levels after Rituximab in RA predicts clinical response
    Dass, S.
    Burgoyne, C. H.
    Vital, E. M.
    Reece, R. J.
    Rawstron, A. C.
    Ponchel, F.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 90 - 90
  • [9] High granulocytic myeloid-derived suppressor cell levels in the peripheral blood predict a better IVF treatment outcome
    Zhu, Mengchen
    Huang, Xiaomin
    Yi, Shanling
    Sun, Haixiang
    Zhou, Jianjun
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (07): : 1092 - 1097
  • [10] Rituximab toxicity in patients with peripheral blood malignant B-cell lymphocytosis
    Kanelli, S
    Ansell, SM
    Habermann, TM
    Inwards, DJ
    Tuinstra, N
    Witzig, TE
    [J]. LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1329 - 1337
12345